±¹³»µµ¼
Àü°øµµ¼/´ëÇб³Àç
ÀǾàÇа£È£°è¿
2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.
Á¤°¡ |
50,000¿ø |
---|
50,000¿ø
1,500P (3%Àû¸³)
ÇÒÀÎÇýÅÃ | |
---|---|
Àû¸³ÇýÅà |
|
|
|
Ãß°¡ÇýÅÃ |
|
À̺¥Æ®/±âȹÀü
¿¬°üµµ¼
»óÇ°±Ç
ÀÌ»óÇ°ÀÇ ºÐ·ù
Ã¥¼Ò°³
Winter¡¯s Basic Clinical Pharmacokinetics 6th editionÀº University of Southern CaliforniaÀÇ Paul M. Beringer, PharmD.¿¡ ÀÇÇØ »õ·ÎÀÌ ÆíÁýµÇ¾ú´Ù. 5th edition¿¡ ¾ø´ø ¡®¼Ò¾ÆȯÀÚ(pediatrics)¡¯¿Í ¡®¾à¹°À¯ÀüÇÐ(pharmacogenomics)¡¯ÀÌ Ãѷп¡ Ãß°¡µÇ¾ú´Ù. ¼Ò¾Æ ȯÀÚµéÀÇ Æ¯Â¡°ú ÀÓ»ó¾àµ¿ÇÐ ÀÚ¹® ½Ã ÁÖÀÇÇÒ Á¡µé¿¡ ´ëÇØ ¾ð±ÞÇÏ¿´´Ù. ÃÖ±Ù ¾à¹°À¯ÀüÇÐÀÌ È¯ÀÚµé °£ÀÇ ¾àµ¿/¾à·ÂÇÐÀû Â÷À̸¦ ¼³¸íÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ º¯ÀÌ ÀÎÀÚ·Î ¸¹Àº ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ´Â Á¡À» °í·ÁÇÒ ¶§ ÇʼöÀûÀ¸·Î ´Ù·ç¾îÁ®¾ß ÇÒ »çÇ×ÀÌ´Ù. ¶ÇÇÑ °¢·Ð¿¡´Â triazole°è Ç×Áø±ÕÁ¦(fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole)¿Í busulfan ¹× mycophenolic acid°¡ Ãß°¡µÇ¾ú°í, ethosuximide, lidocaine ¹× theophyllineÀº »èÁ¦µÇ¾ú´Ù.
ȯÀÚµéÀÇ therapeutic drug monitoring (TDM) ¾÷¹«¸¦ ´ã´çÇÏ°í ÀÖ´Â ÀÓ»óÀdzª ÀÓ»ó¾à»çµéÀº ¹°·Ð ÀÓ»ó¾àµ¿ÇÐÀ» °øºÎÇÏ°íÀÚ ÇÏ´Â µ¶ÀÚµéÀ» À§ÇØ °¡´ÉÇÑ ¿øº»¿¡ Ãæ½ÇÇÏ°Ô ¹ø¿ªÇϱâ À§ÇØ ³ë·ÂÇÏ¿´À¸³ª, ¼³¸íÀÌ Áߺ¹µÇ´Â ³»¿ë, µ¿ÀÏ °³³äÀÌ ¹Ýº¹µÇ´Â ³»¿ë¿¡ ´ëÇؼ´Â ÀǹÌÀÇ ÀûÀýÇÑ Àü´ÞÀ» À§ÇØ ÀϺΠÀÇ¿ªÀ¸·Î ó¸®ÇÏ¿´´Ù. ¿µ¾î¿Í ¿ì¸® ¸»ÀÇ ¾î¹ý»ó Â÷ÀÌÁ¡À» °¨¾ÈÇÏ¿© °¡´ÉÇÑ ÀÚ¿¬½º·´°Ô ¹ø¿ªÇϵµ·Ï ÇÏ¿´À¸¸ç, ¿ø¼ÀÇ ÀüÈÄ ¹®¸Æ°ú °ü·Ã ¹®ÇåµéÀ» Åä´ë·Î ³»¿ëÀ» ¼öÁ¤ÇÏ¿´´Ù. ¿ø Àú¼ÀÇ ¿À·ù ºÎºÐÀº Beringer ±³¼ö¿Í À̸ÞÀÏÀ» ÅëÇØ »óÀÇ ÈÄ ¼öÁ¤Åä·Ï ÇÏ¿´À¸¸ç, º» ¹ø¿ªº»¿¡µµ ¹Ý¿µÇÏ¿´´Ù.
¸ñÂ÷
PART I ¾àµ¿ÇÐÀÇ ±âº» °³³ä
Chapter 1 ¾àµ¿Çаú ¾àµ¿ÇÐ ÆĶó¹ÌÅÍ
Chapter 2 ÀûÀýÇÑ ½ÄÀÇ ¼±Åðú Ç÷Á߾๰³óµµ Çؼ®
Chapter 3 ½ÅÁúȯ ¹× Åõ¼® ȯÀÚÀÇ ¾à¹°Åõ¿©
Chapter 4 ¼Ò¾ÆȯÀÚ¿¡¼ÀÇ ¾àµ¿ÇÐ
Chapter 5 ¾à¹°À¯ÀüÇÐ
PART II ¾à¹° °¢·Ð
Chapter 6 ¾Æ¹Ì³ë±Û¶óÀÌÄÚ»çÀ̵å Ç×»ýÁ¦
Chapter 7 Triazol°è Ç×Áø±ÕÁ¦
Chapter 8 Ä«¸£¹Ù¸¶Á¦ÇÉ(Carbamazepine)
Chapter 9 ¼¼Æ÷µ¶¼º Ç×¾ÏÁ¦: ¸ÞÅäÆ®·º¼¼ÀÌÆ®, ºÎ¼³ÆÇ
Chapter 10 µð°î½Å(Digoxin)
Chapter 11 ¸é¿ª¾ïÁ¦Á¦(Cyclosporine, tacrolimus, sirolimus, mycophenolic acid)
Chapter 12 ¸®Æ¬(Lithium)
Chapter 13 Æä³ë¹ßºñÅ»(Phenobarbital)
Chapter 14 Æä´ÏÅäÀÎ(Phenytoin)
Chapter 15 ¹ßÇÁ·Î»ê(Valproic acid)
Chapter 16 ¹ÝÄÚ¸¶À̽Å(Vancomycin)
ºÎ·Ï
ºÎ·Ï 1 Nomograms for Calculating Body Surface Area
ºÎ·Ï 2 Common Equations Used Throughout the Text
ºÎ·Ï 3 Algorithm for Evaluating and Interpreting Plasma Concentrations
ºÎ·Ï 4 Glossary of Terms and abbreviations
º»¹®Áß¿¡¼
¸Ó¸®¸»
Winter¡¯s Basic Clinical Pharmacokinetics 6th editionÀº University of Southern CaliforniaÀÇ Paul M. Beringer, PharmD.¿¡ ÀÇÇØ »õ·ÎÀÌ ÆíÁýµÇ¾ú´Ù. 5th edition¿¡ ¾ø´ø ¡®¼Ò¾ÆȯÀÚ(pediatrics)¡¯¿Í ¡®¾à¹°À¯ÀüÇÐ(pharmacogenomics)¡¯ÀÌ Ãѷп¡ Ãß°¡µÇ¾ú´Ù. ¼Ò¾Æ ȯÀÚµéÀÇ Æ¯Â¡°ú ÀÓ»ó¾àµ¿ÇÐ ÀÚ¹® ½Ã ÁÖÀÇÇÒ Á¡µé¿¡ ´ëÇØ ¾ð±ÞÇÏ¿´´Ù. ÃÖ±Ù ¾à¹°À¯ÀüÇÐÀÌ È¯ÀÚµé °£ÀÇ ¾àµ¿/¾à·ÂÇÐÀû Â÷À̸¦ ¼³¸íÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ º¯ÀÌ ÀÎÀÚ·Î ¸¹Àº ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ´Â Á¡À» °í·ÁÇÒ ¶§ ÇʼöÀûÀ¸·Î ´Ù·ç¾îÁ®¾ß ÇÒ »çÇ×ÀÌ´Ù. ¶ÇÇÑ °¢·Ð¿¡´Â triazole°è Ç×Áø±ÕÁ¦(fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole)¿Í busulfan ¹× mycophenolic acid°¡ Ãß°¡µÇ¾ú°í, ethosuximide, lidocaine ¹× theophyllineÀº »èÁ¦µÇ¾ú´Ù.
ȯÀÚµéÀÇ therapeutic drug monitoring (TDM) ¾÷¹«¸¦ ´ã´çÇÏ°í ÀÖ´Â ÀÓ»óÀdzª ÀÓ»ó¾à»çµéÀº ¹°·Ð ÀÓ»ó¾àµ¿ÇÐÀ» °øºÎÇÏ°íÀÚ ÇÏ´Â µ¶ÀÚµéÀ» À§ÇØ °¡´ÉÇÑ ¿øº»¿¡ Ãæ½ÇÇÏ°Ô ¹ø¿ªÇϱâ À§ÇØ ³ë·ÂÇÏ¿´À¸³ª, ¼³¸íÀÌ Áߺ¹µÇ´Â ³»¿ë, µ¿ÀÏ °³³äÀÌ ¹Ýº¹µÇ´Â ³»¿ë¿¡ ´ëÇؼ´Â ÀǹÌÀÇ ÀûÀýÇÑ Àü´ÞÀ» À§ÇØ ÀϺΠÀÇ¿ªÀ¸·Î ó¸®ÇÏ¿´´Ù. ¿µ¾î¿Í ¿ì¸® ¸»ÀÇ ¾î¹ý»ó Â÷ÀÌÁ¡À» °¨¾ÈÇÏ¿© °¡´ÉÇÑ ÀÚ¿¬½º·´°Ô ¹ø¿ªÇϵµ·Ï ÇÏ¿´À¸¸ç, ¿ø¼ÀÇ ÀüÈÄ ¹®¸Æ°ú °ü·Ã ¹®ÇåµéÀ» Åä´ë·Î ³»¿ëÀ» ¼öÁ¤ÇÏ¿´´Ù. ¿ø Àú¼ÀÇ ¿À·ù ºÎºÐÀº Beringer ±³¼ö¿Í À̸ÞÀÏÀ» ÅëÇØ »óÀÇ ÈÄ ¼öÁ¤Åä·Ï ÇÏ¿´À¸¸ç, º» ¹ø¿ªº»¿¡µµ ¹Ý¿µÇÏ¿´´Ù.
¿Ï¼ºµµ°¡ ³ôÀº ¹ø¿ªÀ» À§ÇØ ³ë·ÂÇÏ¿´À¸³ª ¹ÌÁøÇÑ ºÎºÐ¿¡ ´ëÇؼ´Â µ¶ÀÚµéÀÇ ÁöµµÆí´ÞÀ» ±â´ëÇϸç, ÀÓ»ó¾àµ¿ÇÐÀÇ ÀÌ·Ð ¹× ½Ç¹«¿¡ µµ¿òÀÌ µÇ±æ ¹Ù¶õ´Ù.
ÀúÀÚ¼Ò°³
»ý³â¿ùÀÏ | - |
---|
ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.
»ý³â¿ùÀÏ | - |
---|
ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.
»ý³â¿ùÀÏ | - |
---|
ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.
ÁÖ°£·©Å·
´õº¸±â»óÇ°Á¤º¸Á¦°ø°í½Ã
À̺¥Æ® ±âȹÀü
Àü°øµµ¼/´ëÇб³Àç ºÐ¾ß¿¡¼ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥
ÆǸÅÀÚÁ¤º¸
»óÈ£ |
(ÁÖ)±³º¸¹®°í |
---|---|
´ëÇ¥ÀÚ¸í |
¾Èº´Çö |
»ç¾÷ÀÚµî·Ï¹øÈ£ |
102-81-11670 |
¿¬¶ôó |
1544-1900 |
ÀüÀÚ¿ìÆíÁÖ¼Ò |
callcenter@kyobobook.co.kr |
Åë½ÅÆǸž÷½Å°í¹øÈ£ |
01-0653 |
¿µ¾÷¼ÒÀçÁö |
¼¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù) |
±³È¯/ȯºÒ
¹ÝÇ°/±³È¯ ¹æ¹ý |
¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼ ½Åû °¡´É |
---|---|
¹ÝÇ°/±³È¯°¡´É ±â°£ |
º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É |
¹ÝÇ°/±³È¯ ºñ¿ë |
º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã |
¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯ |
·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì |
»óÇ° Ç°Àý |
°ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½ |
¼ÒºñÀÚ ÇÇÇغ¸»ó |
·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© ó¸®µÊ ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀǼҺñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ |
(ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
(ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.
¹è¼Û¾È³»
±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
Ãâ°í°¡´É ½Ã°£ÀÌ ¼·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.
±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.
¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.